lestaurtinib has been researched along with deoxycytidine in 2 studies
| Studies (lestaurtinib) | Trials (lestaurtinib) | Recent Studies (post-2010) (lestaurtinib) | Studies (deoxycytidine) | Trials (deoxycytidine) | Recent Studies (post-2010) (deoxycytidine) |
|---|---|---|---|---|---|
| 124 | 12 | 63 | 18,160 | 4,652 | 8,898 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, J; Chan, E; Holen, KD; Lockhart, AC; Mulkerin, D; Rothenberg, M; Thomas, J | 1 |
| Parks, RJ; Saha, B | 1 |
1 trial(s) available for lestaurtinib and deoxycytidine
| Article | Year |
|---|---|
A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Deoxycytidine; Drug Administration Schedule; Drug Interactions; Female; Furans; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Pancreatic Neoplasms | 2008 |
1 other study(ies) available for lestaurtinib and deoxycytidine
| Article | Year |
|---|---|
Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Antiviral Agents; Carbazoles; Deoxycytidine; Furans; Gemcitabine; Humans; Piperazines; Virus Replication | 2021 |